RT
Renee P Tannenbaum (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $146K of ANIP (1,800 sh × $81.15, as filed), executed Dec 5 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$146K
shares × price, as filed
Last traded
Dec 5 2025
Filed Dec 9 2025
Median ADV $26.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $146K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ANIPRecent filings
ANIPSALE
ANI Pharmaceuticals, Inc.
View filing →
$146K1,800 sh × $81.15
Exec Dec 5 2025
Filed Dec 9 2025 · 5:30 PM ET